Headlines
Most Voted
Most Discussed
Vioxx & Celebrex Raise Risk of First & Repeat Heart Attack: Large StudyA large study, conducted by Dr. James M. Brophy and his colleagues, from the McGill University Health Center in Montreal, confirms that selective COX2 inhibitors - Vioxx (rofecoxib) and Celebrex (celecoxib) are both associated with increased risk of repeat heart attack. They also found that Vioxx (rofecoxib), but not Celebrex (celecoxib), is associated with increased risk of a first heart attack. Prudential Analyst sees Merck Losing Vioxx LawsuitThe odds are against Merck & Co. prevailing in a wrongful-death civil Vioxx lawsuit being tried in Texas, an analyst at Prudential Equity Group says. It is the first Vioxx-related lawsuit to come to trial. Vioxx Tied to Cause of Death by Doctor in First Vioxx LawsuitA doctor told jurors yesterday in the nation's first Vioxx lawsuit that the drug contributed to the death of a Texas man, aged 59, who had an arrhythmia linked to a heart attack in 2001. Past Patent Application could Implicate Vioxx Makers, Merck, in the ongoing Vioxx LawsuitMerck tried to patent a drug that would reduce heart attack risks for Vioxx (COX-2 selective inhibitors) users, three years before the company withdrew the painkiller drug from the market because of safety concerns. Understanding Context Aware Trackback Spamming: New Frontiers in Web SpammingLet's begin with an example.
|
Topics (map)
Taragana NetworkBlog StatsThere are currently 5,846 posts and 15,394 comments in this weblog. Enjoy!
9748644 translated pages served by Angsuman's Translator Plugin Gold since May 2007.
Cache hit : 96.65% Cache miss : 3.35% Poll Loading ...Latest TweetsVioxx
Latest Friend FeedsVioxx
|
